gestrinone has been researched along with Fibroid in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (46.67) | 18.7374 |
| 1990's | 5 (33.33) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Centini, G; Kashani, BN; Morelli, SS; Petraglia, F; Weiss, G | 1 |
| Cao, L; Cao, Y; Guo, X; Tu, R; Xie, S; Zhang, T; Zhou, J; Zhou, X; Zhu, Y | 1 |
| Cao, L; He, GL; Jiang, XR; Liu, GM; Qiu, XY; Sun, ZY; Wang, L; Wu, JH; Zhu, Y | 1 |
| Coutinho, EM | 3 |
| Ezhova, LS; Ishchenko, IG; Landekhovskiĭ, IuD; Mishchenko, AL | 1 |
| Stovall, TG | 1 |
| Vikhliaeva, EM | 1 |
| Erny, R; Milliet, E | 1 |
| Coutinho, EM; Gonçalves, MT | 1 |
| Fujii, S; Konishi, I; Mori, T | 1 |
| Baird, DT; West, CP | 1 |
| Boulanger, GA; Coutinho, EM; Gonçalves, MT | 1 |
| Kadota, T; Okamura, Y; Otsuka, H; Yoshida, K | 1 |
3 review(s) available for gestrinone and Fibroid
| Article | Year |
|---|---|
Role of Medical Management for Uterine Leiomyomas.
Topics: Antifibrinolytic Agents; Aromatase Inhibitors; Cabergoline; Cholecalciferol; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Danazol; Dopamine Agonists; Ergolines; Estrenes; Estrogen Antagonists; Female; Gestrinone; Gonadotropin-Releasing Hormone; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Mifepristone; Norpregnadienes; Oximes; Patient Care Planning; Selective Estrogen Receptor Modulators; Somatostatin; Tranexamic Acid; Uterine Neoplasms; Vitamins | 2016 |
Gonadotropin-releasing hormone agonists: utilization before hysterectomy.
Topics: Anemia; Clinical Trials as Topic; Combined Modality Therapy; Danazol; Drug Administration Schedule; Female; Gestrinone; Gonadotropin-Releasing Hormone; Humans; Hysterectomy; Iron Compounds; Leiomyoma; Preoperative Care; Progestins; Uterine Neoplasms | 1993 |
Medical management of fibroids.
Topics: Adult; Female; Gestrinone; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Medrogestone; Menopause; Uterine Neoplasms | 1988 |
5 trial(s) available for gestrinone and Fibroid
| Article | Year |
|---|---|
[Changes in the hemostatic system in anomalous uterine hemorrhages and uterine myoma at perimenopause].
Topics: Danazol; Female; Gestrinone; Hemostasis; Humans; Leiomyoma; Menopause; Middle Aged; Time Factors; Uterine Hemorrhage; Uterine Neoplasms | 1993 |
Treatment of large fibroids with high doses of gestrinone.
Topics: Adult; Female; Gestrinone; Humans; Leiomyoma; Time Factors; Ultrasonography; Uterine Neoplasms; Uterus | 1990 |
Long-term treatment of leiomyomas with gestrinone.
Topics: Administration, Intravaginal; Adult; Clinical Trials as Topic; Drug Administration Schedule; Female; Gestrinone; Humans; Leiomyoma; Norpregnatrienes; Pregnancy; Prospective Studies; Random Allocation; Ultrasonography; Uterine Neoplasms | 1989 |
Gestrinone in the treatment of myomas.
Topics: Adolescent; Adult; Female; Gestrinone; Humans; Leiomyoma; Middle Aged; Norpregnatrienes; Prospective Studies; Randomized Controlled Trials as Topic; Uterine Neoplasms | 1989 |
Regression of uterine leiomyomas after treatment with gestrinone, an antiestrogen, antiprogesterone.
Topics: Adolescent; Adult; Female; Gestrinone; Humans; Leiomyoma; Middle Aged; Norpregnatrienes; Time Factors; Ultrasonography; Uterine Neoplasms; Uterus | 1986 |
7 other study(ies) available for gestrinone and Fibroid
| Article | Year |
|---|---|
Gestrinone inhibits growth of human uterine leiomyoma may relate to activity regulation of ERα, Src and P38 MAPK.
Topics: Apoptosis; Blotting, Western; Cell Culture Techniques; Cell Cycle; Cell Proliferation; Cell Survival; CSK Tyrosine-Protein Kinase; Dose-Response Relationship, Drug; Estrogen Receptor alpha; Female; Gestrinone; Humans; In Situ Nick-End Labeling; Leiomyoma; Microscopy, Electron, Transmission; Molecular Structure; p38 Mitogen-Activated Protein Kinases; Real-Time Polymerase Chain Reaction; src-Family Kinases; Time Factors; Tumor Cells, Cultured; Uterine Neoplasms | 2012 |
Effects of gestrinone on uterine leiomyoma and expression of c-Src in a guinea pig model.
Topics: Animals; CSK Tyrosine-Protein Kinase; Female; Gene Expression; Gestrinone; Guinea Pigs; Leiomyoma; Models, Molecular; Ovariectomy; Progestins; Protein-Tyrosine Kinases; Random Allocation; src-Family Kinases; Uterine Neoplasms; Uterus | 2007 |
Conservative treatment of uterine leiomyoma with the antiestrogen antiprogesterone R-2323.
Topics: Administration, Oral; Adult; Amenorrhea; Estrogen Antagonists; Female; Gestrinone; Humans; Leiomyoma; Male; Middle Aged; Norpregnatrienes; Pregnancy; Progesterone; Twins; Ultrasonography; Uterine Neoplasms | 1981 |
[Adjuvant therapy in uterine myoma].
Topics: Adult; Age Factors; Chemotherapy, Adjuvant; Clinical Trials as Topic; Danazol; Estradiol; Estrogen Antagonists; Female; Follicle Stimulating Hormone; Gestrinone; Humans; Leiomyoma; Luteinizing Hormone; Middle Aged; Progesterone; Progesterone Congeners; Testosterone; Time Factors; Uterine Neoplasms | 1997 |
[Treatment of uterine fibroma using LH-RH analogs and gestrinone. Limits and indications].
Topics: Administration, Intranasal; Adolescent; Adult; Buserelin; Female; Gestrinone; Humans; Leiomyoma; Middle Aged; Norpregnatrienes; Remission Induction; Uterine Neoplasms | 1990 |
[Pathogenesis and conservative therapy of uterine leiomyoma].
Topics: Buserelin; Danazol; Estrogens; Female; Gestrinone; Humans; Leiomyoma; Progesterone; Uterine Neoplasms | 1986 |
[The effect of a synthetic progestin (R 2323) on gonadal and endometrial cells in vitro and in vivo].
Topics: Adult; Aged; Animals; Cell Division; Cells, Cultured; Endometrium; Estradiol; Female; Gestrinone; Gonadotropins; Granulosa Cells; Humans; Leiomyoma; Norpregnatrienes; Progesterone; Swine; Uterine Neoplasms | 1985 |